These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23829547)

  • 1. Monoclonal gammopathy of undetermined significance and anti-TNF-α treatment: comments on the article by Smale and Lawson.
    Mielnik P; Hjelle AM; Szatkowski D
    Scand J Rheumatol; 2013; 42(4):335-6. PubMed ID: 23829547
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal gammopathy of undetermined significance and anti-TNF-alpha treatment.
    Smale SW; Lawson TM
    Scand J Rheumatol; 2007; 36(5):405-6. PubMed ID: 17963174
    [No Abstract]   [Full Text] [Related]  

  • 3. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
    Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
    Dermatology; 2008; 217(4):380. PubMed ID: 18849606
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Hochman D; Wolff B
    JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Callegari PE; Schaible TF; Boscia JA
    JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Costenbader KH; Glass R; Cui J; Shadick N
    JAMA; 2006 Nov; 296(18):2201; author reply 2203-4. PubMed ID: 17090761
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis.
    Day R
    Lancet; 2002 Feb; 359(9306):540-1. PubMed ID: 11867103
    [No Abstract]   [Full Text] [Related]  

  • 8. Pneumonitis caused by Legionella pneumoniae in a patient with rheumatoid arthritis treated with anti-TNF-alpha therapy (infliximab).
    Li Gobbi F; Benucci M; Del Rosso A
    J Clin Rheumatol; 2005 Apr; 11(2):119-20. PubMed ID: 16357717
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Okada SK; Siegel JN
    JAMA; 2006 Nov; 296(18):2201-2; author reply 2203-4. PubMed ID: 17090760
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericardial effusions on anti-TNF therapy for rheumatoid arthritis--a drug side effect or uncontrolled systemic disease?
    Edwards MH; Leak AM
    Rheumatology (Oxford); 2009 Mar; 48(3):316-7. PubMed ID: 19106166
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-TNF-alpha therapies: they are all the same (aren't they?).
    Mpofu S; Fatima F; Moots RJ
    Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
    [No Abstract]   [Full Text] [Related]  

  • 13. Unstable diabetes in a patient receiving anti-TNF-alpha for rheumatoid arthritis.
    Boulton JG; Bourne JT
    Rheumatology (Oxford); 2007 Jan; 46(1):178-9. PubMed ID: 16998233
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.
    Vandevyvere K; Luyten FP; Verschueren P; Lories R; Segaert S; Westhovens R
    Clin Rheumatol; 2007 Dec; 26(12):2205-2206. PubMed ID: 17876646
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serious lung disease in RA and TNF-blockade--is there a connection?].
    Turesson C; Jacobsson L; Saxne T; Geborek P
    Lakartidningen; 2006 Feb 1-7; 103(5):308; author reply 308-9. PubMed ID: 16512575
    [No Abstract]   [Full Text] [Related]  

  • 16. [TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].
    MMW Fortschr Med; 2002 May; 144(20):65. PubMed ID: 12119893
    [No Abstract]   [Full Text] [Related]  

  • 17. Comments on Falgarone et al. editorial entitled "TNFalpha antagonists in rheumatoid arthritis patients seen in everyday practice".
    Legoff P
    Joint Bone Spine; 2008 Oct; 75(5):626; author reply 626. PubMed ID: 18805723
    [No Abstract]   [Full Text] [Related]  

  • 18. Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor alpha for rheumatoid arthritis: a case report and discussion of literature.
    Silburn S; McIvor E; McEntegart A; Wilson H
    Ann Rheum Dis; 2008 Apr; 67(4):575-6. PubMed ID: 18349168
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactivation of brucellosis after treatment with infliximab in a patient with rheumatoid arthritis.
    Jiménez FG; Colmenero JD; Irigoyen MV
    J Infect; 2005 May; 50(4):370-1. PubMed ID: 15845443
    [No Abstract]   [Full Text] [Related]  

  • 20. Are we content that risk of cancer is not appreciably increased after tumor necrosis factor inhibitor use? Comment on the article by Solomon et al.
    Yazici H; Yazici Y
    Arthritis Rheum; 2012 Jul; 64(7):2414; author reply 2414-5. PubMed ID: 22549846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.